<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Onchocerciasis (River Blindness)</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>

    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterðŸ’œ</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>

    <h1>Onchocerciasis (River Blindness)</h1>
  
    <!-- <div class="author-flex">
      <div class="author-img">
        <img  src="/contributors/vt1.jpeg" alt="">
      </div>
      <div>
        <h2 class="name">Compiled by Victortayo</h2>
        <p class="updated">last updated, Nov 2022</p>
      </div>
    </div> -->

    <article class="notes">
        <a id='top'></a>
    <article>
    <!-- <h2 class='title'>Outline</h2> -->
    <div class="outline2">

      <input type="radio" name="control-2" id="show-2">
      <label for="show-2">Show Outline</label>
      <input type="radio" name="control-2" id="hide-2">
      <label for="hide-2">Hide Outline</label>
      <div class="contents">
         <ol>
            <li><a href="#header-1">Introduction </a></li>
            <li><a href="#header-2">Epidemiology</a></li>
            <li><a href="#header-3">Signs and symptoms</a></li>
            <li><a href="#header-4">Endemicity Assessment</a></li>
            <li><a href="#header-5">Diagnosis</a></li>
            <li><a href="#header-6">Control</a></li>
            <li><a href="#header-7">What is being done?</a></li>
         </ol>
      </div>
     <div>

      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction </a>
          </h2>
        </header>
        <div class='body'>
            <p>River Blindness, a parasitic disease, is the second leading infectious cause of blindness.</p>
            <figure>
                <img src="../figures/onchocerciasis (3).png" alt="">
                <figcaption> </figcaption>
            </figure>
            <p>River Blindness is caused by a round worm, onchocerca volvulus</p>
            <figure>
                <img src="../figures/onchocerciasis (1).jpg" alt="">
                <figcaption> </figcaption>
               </figure>
            <p>It is one of the tropical diseases for research (TDR)</p>
            <p><span class="special-text">Reservoir</span>: Humans</p>
            <p><span class="special-text">Vector</span>: Simulium damnosum (Blackfly)</p>
            <ul>
                <li>Can breed at high altitudes (610m or more)</li>
                <li>Larvae and pupae are found attached to highly oxygenated waters. Infection occurs in proximity to fast moving water (river blindness)</li>
                <li>The period of greatest transmission is in the rainy season coinciding with the period of maximal Simulium breeding.</li>
            </ul>
            <p>River blindness is transmitted to humans by the blackfly</p>
            <figure>
                <img src="../figures/onchocerciasis (2).jpg" alt="">
                <figcaption> </figcaption>
            </figure>

            
        </div>

      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Epidemiology</a>
          </h2>
        </header>
        <div class='body'>
            <p>The adult worms are found in subcutaneous nodules and tissue spaces.</p>
            <p>The females, which are ovoviviparous, measure about 30-80cm in length while the males are only 3-5cm long.</p>
            <P>Worms of both sexes are found coiled together in nodules and larvae are present in large numbers near the coiled gravid female.</P>
            <P>The developed larvae (microfilariae) vary in size (250-300um) and are unsheathed</P>
            <P>The lifespan is between 9-14years</P>
            <P>Has a focal distribution in both Africa and Central America.</P>
            <figure>
                <img src="../figures/onchocerciasis (4).png" alt="">
                <figcaption> </figcaption>
               </figure>
            <p>99 percent of River Blindness cases occur in Africa</p>
            <p>36 countries</p>
            <ul>
                <li>29 in sub-Saharan Africa</li>
                <li>6 in Latin America</li>
                <li>Yemen</li>
            </ul>
            <P>Endemic in West Africa, equatorial & east Africa & Sudan</P>
            <P>One of the largest endemic areas occur in the Volta River Basin area, which incorporates parts of Benin, Ghana, Ivory coast, Mali, Niger, Togo and Burkina Faso. These are the areas of the onchocerciasis control program (OCP)</P>
            <P>Males are more affected than females (? occupational hazards)</P>
            <P>Incidence of infection increases with age (up to 75% of middle aged in endemic area might be infected)</P>

            <figure>
                <img src="../figures/onchocerciasis (1).png" alt="">
                <figcaption>Life cycle </figcaption>
               </figure>
        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Signs and symptoms</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>Rashes</li>
                <li>Lesions</li>
                <li>Intense itching</li>
                <li>Depigmentation of the skin</li>
                <li>Lymphadenitis</li>
                <li>General debilitation</li>
                <li>Serious visual impairment</li>
                <li>Blindness</li>

                <figure>
                    <img src="../figures/onchocerciasis (3).jpg" alt="">
                    <figcaption> </figcaption>
                   </figure>
            </ul>
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Endemicity Assessment</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li>Rapid epidemiological assessment (REA)</li>
                <li>Rapid epidemiological mapping of onchocerciasis (REMO)</li>
            </ul>

            <section id='heading-4-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-1'>Rapid epidemiological assessment (REA)</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>REA refers to a broad collection of epidemiological, statistical and anthropological techniques which aim to provide accurate information quickly, at a low cost, in a simple format.</p>

                   <h4><span class="special-text-4b">Historical aspects of REA</span></h4>
                   <p>1981, ACHBRD was formed to identify areas of research to improve health of developing countries.</p>
                   <p>WHO developed novel <b>epidemiological sampling</b>  and <b>surveillance methods</b>  for smallpox eradication in EPI. The committee named them Rapid Epidemiological Assessment.</p>
                   <p>REA began as an amalgam of concepts and techniques borrowed from the fields of health services research and operations research, as well as traditional epidemiology.</p>
                   <p>It was largely inspired by the â€˜quick and dirtyâ€™ methods of epidemiology.</p>

                   <h4><span class="special-text-4b">Aspects of Rapid Methods</span></h4>
                    <ol>
                        <li>Sampling methods for rapid health assessment</li>
                        <ul>
                            <li>WHO-EPI cluster sampling</li>
                            <li>LQAS</li>
                            <li>Case control methodology</li>
                        </ul>
                        <li>Collection, organization and analysis of data</li>
                        <p>Methods of data collection</p>
                        <ul>
                            <li>Focused group discussion</li>
                            <li>Key-informant interviews</li>
                            <li>Observations</li>
                            <li>Case reports</li>
                            <li>Personal diaries</li>
                            <li>Conversations</li>
                            <li>Participant observations</li>
                            <li>Collection of data from secondary sources</li>
                        </ul>
                        <p>Methods of organizing, analyzing and presenting data</p>
                        <ul>
                            <li>Geographical information systems</li>
                        </ul>
                        <li>Rapid management in emergency situations</li>
                    </ol>
                </div>
            </section>

            <section id='heading-4-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-4-2'>Rapid Epidemiological Mapping of Onchocerciasis (REMO) </a>
                  </h3>
                </header>
                <div class='body'>
                   <p>REMO uses <b>nodule palpation</b>  in combination with <b>geographic information system mapping</b>, and was used by African Programme for Onchocerciasis Control (APOC) to map prevalence in 20 countries from 1996 to 2012. </p>
                   <p>REMO revealed that the prevalence of Onchocerca volvulus nodules was patchy and heterogenous across Africa and identified areas for ivermectin intervention using a threshold for treatment set at a nodule prevalence of 20%. Onchocerciasis-endemic communities were divided into 3 based on nodule prevalence. </p>
                   <ul>
                    <li>Hypoendemic (nodule prevalence of < 20%) </li>
                    <li>Mesoendemic (nodule prevalence of 20â€”45%) </li>
                    <li>Hyperendemic (nodule prevalence >45%) </li>
                   </ul>
                </div>
            </section>
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Diagnosis</a>
          </h2>
        </header>
        <div class='body'>
            <section id='heading-5-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-5-1'>Laboratory</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Examination of Skin or conjunctival snips</p>
                   <p>Excision of nodules for histological examination</p>
                   <p>Aspiration of fluid from nodules</p>
                </div>
            </section>

            <section id='heading-5-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-5-2'>Serology</a>
                  </h3>
                </header>
                <div class='body'>
                   <p>Complement fixation</p>
                   <p>Immunofluorescence</p>
                   <p>ELISA</p>
                </div>
            </section>
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Control</a>
          </h2>
        </header>
        <div class='body'>
            <h4><span class="special-text-4b">The vector</span></h4>
            <p>Attack the breeding site</p>
            <h4><span class="special-text-4b">The human reservoir</span></h4>
            <p>Chemotherapy: Ivermetin (Mectizan)</p>
            <ul>
                <li>Ivermectin is a broad-spectrum antiparasitic drug that can be used to treat river blindness</li>
                <li>Ivermectin does not kill adult worms, but prevents them from producing additional offspring</li>
                <li>Drug binds to and activates glutamate-gated chloride channels</li>
                <li>By activating channels, drug causes inhibitory postsynaptic potential</li>
                <li>Microfilaria experience paralysis and then death</li>
            </ul>
            <p>Nodulectomy</p>
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'>What is being done? </a>
          </h2>
        </header>
        <div class='body'>
           <p>Mectizan Donation Program (1987)</p>
           <p>IDP: Ivermectin Distribution Program (1989-1994)</p>
           <p>OCP: Onchocerciasis Control Programme (1988)</p>
           <p>APOC: African Programme for Onchocerciasis Control (1995)</p>
           <p>The Carter Center (1996)</p>

           <h4><span class="special-text-4"></span></h4>
            <p>Angola, Burundi, Cameroon, Central African Republic, Chad, Congo, Democratic Republic of Congo, Ethiopia, Equatorial Guinea, Gabon, Kenya, Liberia, Malawi, Mozambique, <b>Nigeria</b>, Rwanda, Sudan, Tanzania and Uganda.</p>
            <figure>
                <img src="../figures/onchocerciasis (2).png" alt="">
                <figcaption> </figcaption>
            </figure>
        </div>
      </section>





      </section>

      <div class="contact">
        <hr style="margin: 3rem 0;">

        <div class="comment">
        <p>Send your comments, corrections, explanations/clarifications and requests/suggestions to our <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">WhatsApp group</a>.</p>
        </div>
      </div>
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The content on this â€˜Websiteâ€™, including but not limited to text, graphics, images, videos, and other materials, should not be considered as a substitute for formal medical education or clinical training. The creators and operators of this Website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the Website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this Website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>     
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiðŸ‘‹</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
</body>
</html>
 
